Early generation left ventricular assist devices (LVAD) for treatment of refractory heart failure
attempted to mimic the pulsatility of a native heart and were bulky and less durable due to …

Mechanical circulatory support with implantable durable continuous-flow left ventricular
assist devices (CF-LVADs) represents an established surgical treatment option for patients …

Background Left ventricular assist device (LVAD) placement frequently leads to a reduction
in the severity of functional mitral regurgitation (MR). However, a significant number of LVAD …

Durable left ventricular assist device (LVAD) therapy is an increasingly accepted surgical
therapy for management of advanced heart failure (HF) refractory to guideline-directed …

Abstract Purpose of Review The purpose of this review is to synthesize and summarize
recent developments in the care of patients with end-stage heart failure being managed with …

Functional mitral regurgitation (MR) in the setting of heart failure results from progressive
dilatation of the left ventricle (LV) and mitral annulus. This leads to leaflet tethering with …

Over the last two decades, implantable continuous flow left ventricular assist devices (LVAD)
have proven to be invaluable tools for the management of selected advanced heart failure …

The resolution of functional mitral valve regurgitation (MR) in patients awaiting left
ventricular assist device (LVAD) implantation is discussed controversially. The present study …

Valvular heart disease is common among left ventricular assist device (LVAD) recipients.
However, its management at the time of LVAD implantation remains controversial. Patients …

Background Left ventricular assist devices (LVADs) represent an important therapeutic
option for patients progressing to end‐stage heart failure. LVAD has previously been shown …